News Image

Inhibikase Appoints Industry Veteran Mark Iwicki as CEO to Drive Next Stage of Company’s Growth

Provided By GlobeNewswire

Last update: Feb 18, 2025

-- Mr. Iwicki Brings Track Record of Operational Excellence and Significant Expertise in PAH and Cardiovascular Diseases --

-- Amit Munshi Appointed Chair of the Board of Directors --

Read more at globenewswire.com

INHIBIKASE THERAPEUTICS INC

NASDAQ:IKT (8/25/2025, 8:00:02 PM)

After market: 1.76 0 (0%)

1.76

-0.13 (-6.88%)



Find more stocks in the Stock Screener

IKT Latest News and Analysis

Follow ChartMill for more